Option Care Health (NASDAQ:OPCH) Shares Gap Up on Analyst Upgrade

Shares of Option Care Health, Inc. (NASDAQ:OPCH) gapped up before the market opened on Tuesday after Morgan Stanley raised their price target on the stock from $35.00 to $38.00. The stock had previously closed at $32.06, but opened at $35.25. Morgan Stanley currently has an overweight rating on the stock. Option Care Health shares last traded at $34.9540, with a volume of 717,566 shares.

A number of other equities research analysts have also issued reports on OPCH. Stephens raised Option Care Health to a “strong-buy” rating in a research report on Thursday, December 11th. Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a research note on Tuesday. Jefferies Financial Group reiterated a “buy” rating and issued a $37.00 price objective on shares of Option Care Health in a report on Tuesday. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research report on Friday, October 31st. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Option Care Health in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $37.17.

Insider Activity

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 38,000 shares of Option Care Health stock in a transaction that occurred on Monday, November 3rd. The stock was acquired at an average price of $25.98 per share, for a total transaction of $987,240.00. Following the completion of the acquisition, the director owned 413,390 shares of the company’s stock, valued at approximately $10,739,872.20. This trade represents a 10.12% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.64% of the company’s stock.

Key Stories Impacting Option Care Health

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: Company raised FY2025 and Q4 guidance with FY25 EPS guidance above consensus (1.72–1.76 vs. 1.64 consensus) and Q4 EPS above consensus, supporting better-than-expected profitability outlook.
• Positive Sentiment: Preliminary FY2025 net revenues reported higher, which investors interpreted as validation of the guidance and helped push the stock toward its 52‑week high. Option Care (OPCH) Runs to Near Record on Preliminary FY25 Results
• Positive Sentiment: Analysts raised targets and/or reaffirmed positive ratings (Morgan Stanley raised target to $38 and Citizens/JMP raised target to $38 / reaffirmed market outperform), adding third‑party validation to the company’s outlook. Benzinga coverage of analyst actions TickerReport: Analyst Note
• Neutral Sentiment: Management presented at the J.P. Morgan Healthcare Conference (transcript and slides available) — useful for investor Q&A and strategic detail but not an immediate catalyst beyond reaffirming guidance. J.P. Morgan presentation transcript J.P. Morgan presentation slides
• Neutral Sentiment: A Zacks note highlighted strong intraday price/volume movement but cautioned that recent earnings estimate revision trends may not guarantee continued upside; watch upcoming analyst revisions and next-quarter updates. Zacks: OPCH Moves Higher
• Negative Sentiment: FY2026 revenue guidance ($5.8–6.0B) came in slightly below consensus (~$6.1B), which could limit upside for longer-term top-line expectations despite FY26 EPS guidance that modestly exceeds estimates — a potential headwind if revenue growth disappoints.

Institutional Trading of Option Care Health

A number of hedge funds have recently modified their holdings of the stock. USA Financial Formulas acquired a new position in Option Care Health in the 2nd quarter valued at about $26,000. Cornerstone Planning Group LLC grew its position in shares of Option Care Health by 7,621.4% in the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock valued at $30,000 after purchasing an additional 1,067 shares during the last quarter. Advisory Services Network LLC bought a new position in shares of Option Care Health during the third quarter worth approximately $35,000. McIlrath & Eck LLC acquired a new stake in Option Care Health during the 2nd quarter worth approximately $37,000. Finally, Caitong International Asset Management Co. Ltd acquired a new stake in Option Care Health during the 3rd quarter worth approximately $38,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Price Performance

The company has a current ratio of 1.56, a quick ratio of 1.05 and a debt-to-equity ratio of 0.85. The company has a 50 day moving average of $31.15 and a 200-day moving average of $29.46. The firm has a market capitalization of $5.64 billion, a P/E ratio of 28.18, a P/E/G ratio of 2.17 and a beta of 0.80.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.